Eterna Therapeutics Inc Cash Flow-to-Debt Ratio
Eterna Therapeutics Inc cash flow-to-debt ratio. Eterna Therapeutics Inc (ERNA) has a Cash Flow-to-Debt Ratio of -1.33x as of June 2026, meaning its operating cash flow of $-4.15 Million could theoretically repay -1% of its total liabilities ($3.12 Million) in one year. Check ERNA cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Eterna Therapeutics Inc (2007–2025)
Cash flow-to-debt ratio of Eterna Therapeutics Inc from 2007 to 2025. Historical debt coverage capacity for Eterna Therapeutics Inc across 18 annual periods. Check Eterna Therapeutics Inc cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Eterna Therapeutics Inc Cash Flow-to-Debt Ratio by Year (2007–2025)
Eterna Therapeutics Inc cash flow-to-debt ratio by year from 2007 to 2025. Year-by-year debt coverage analysis for Eterna Therapeutics Inc. For the full cash flow conversion analysis, see Eterna Therapeutics Inc operating cash flow efficiency.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -2.04x | $-7.02 Million | $3.43 Million | ▲ +53.9% |
| 2024 | -4.44x | $-15.84 Million | $3.57 Million | ▼ -920.0% |
| 2023 | -0.44x | $-20.41 Million | $46.90 Million | ▲ +78.9% |
| 2022 | -2.06x | $-20.98 Million | $10.17 Million | ▲ +47.1% |
| 2021 | -3.90x | $-23.49 Million | $6.02 Million | ▼ -152.7% |
| 2020 | -1.54x | $-8.10 Million | $5.25 Million | ▼ -673.1% |
| 2019 | 0.27x | $2.74 Million | $10.19 Million | ▲ +56.9% |
| 2018 | 0.17x | $1.36 Million | $7.95 Million | ▲ +245.2% |
| 2017 | 0.05x | $549.00K | $11.03 Million | ▲ +2727.0% |
| 2016 | 0.00x | $23.00K | $13.07 Million | ▲ +100.5% |
| 2015 | -0.32x | $-4.18 Million | $12.97 Million | ▲ +42.8% |
| 2014 | -0.56x | $-6.38 Million | $11.34 Million | ▼ -335.8% |
| 2013 | 0.24x | $1.49 Million | $6.25 Million | ▼ -47.3% |
| 2012 | 0.45x | $2.16 Million | $4.76 Million | ▲ +317.8% |
| 2011 | 0.11x | $574.00K | $5.30 Million | ▼ -86.0% |
| 2010 | 0.77x | $2.83 Million | $3.66 Million | ▲ +50.6% |
| 2009 | 0.51x | $2.50 Million | $4.88 Million | ▲ +100.4% |
| 2007 | -114.13x | $-604.00 Million | $5.29 Million | — |